Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : A.I.M Users Group Bulletin Board -- Ignore unavailable to you. Want to Upgrade?

To: ubrx who wrote (4718)	5/15/1998 7:46:00 AM
From: OldAIMGuy	Respond to of 18928

Hi JF, Boy, it didn't feel like good money management back in '94 when the price was in the toilet!! On a time-value basis, I probably could have done better other places, but BioTech is such a strange beast. If their human trials work out and they create a cancer curing product, time-value will have no meaning. It's a credit to AIM that I now show a profit on this stock - please remember that the first shares I bought in NERX were at $13.50/share. It's only with AIM's assistance that at $8 I'm now showing a profit of about 45%. Like you said, NERX could have been Mr. L's "Poster Child!!!" Remember when that investment banking house was around NERX? David Blech? I'm not sure. All I know is that progress with R&D is never as fast as one would expect and only a plan like AIM will justify being involved in the early stages. NERX wasn't the first of the Biotechs that I bought, but it was the tiniest. It's a relatively small part of my overall portfolio. If it becomes a big part, I won't mind, :-) but any guess is just that! I which I knew where our our old friend Sully is so I could show him these graphs. He did lots of homework on NERX and was usually pretty good at digging info out on them. Best regards, Tom